Treatment strategies and outcomes for patients with EGFR-mutant non-small cell lung cancer resistant to EGFR tyrosine kinase inhibitors: Focus on novel therapies
Article in Lung Cancer (May 2022)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in Lung Cancer (May 2022)
Article in Clinical Lung Cancer (July 2020)